Dr. Tyrone C. Malloy: Uterine Fibroids

Women’s Health-

Uterine Fibroids                    A Multi-Center, Placebo Controlled, Safety and Efficiacy Study of the Selective Progesterone Receptor Modulator XXXXX in Anemic, Pre-Menopausal Women with Symptomatic Uterine Fibroids Requiring Hysterectomy

Principal Investigator

Sponsor: Repros Therapeutics, Inc.

A Phase 3, Open Label, Two-Arm, Parallel Design, Randomized, Multicenter Study Evaluating the Safety and Efficacy of 25 mg and 50 mg Doses of XXXXX to Assess Recurrence of Symptoms in the Treatment of Premenopausal Women with Symptomatic Uterine Fibroids

                                                Principal Investigator

Sponsor: Repros Therapeutics, Inc.

                              A Phase 3, Open-Label, Parallel, Randomized, Multicenter Study Evaluating the Safety of 25 and 50 mg XXXXX in the Treatment of Premenopausal Women with Symptomatic Uterine Fibroids

                                                Principal Investigator

Sponsor: Repros Therapeutics, Inc.